| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Matthew R Henn is See Remarks at MCRB. From January 2020 to August 2026, the filings on record show 0 open-market purchases and 14 sales. Matthew R Henn's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $16K at current prices.
Our model assigns Matthew R Henn a middling insider score of 69/100, based on 12 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +15.0%.
The MCRB filings lean toward selling, a net 112,200 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE10b5-1 | 891 | $0.94 | $837.54 | -1.3% | -13.6% | -61.3% | |
| Feb 16, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE10b5-1 | 4,170 | $1.08 | $4,503.60 | -6.2% | -12.0% | -20.7% | |
| Oct 30, 2023 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE10b5-1 | 3,886 | $1.35 | $5,246.10 | -6.5% | -13.8% | -46.8% | |
| Dec 1, 2020 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE | 91,812 | $27.04 | $2,482,308.70 | - | - | - |